| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Departments of Physiology (Y.A., P.L.B.) and Medicine (P.L.B.), University of Toronto, Ontario, Canada M5S 1A8
Address all correspondence and requests for reprints to: Dr. Patricia L. Brubaker, Department of Physiology, Medical Sciences Building Room 3366, University of Toronto, 1 Kings College Circle, Toronto, Ontario, Canada M5S 1A8. E-mail: p.brubaker{at}utoronto.ca.
Glucagon-like peptide 1 (GLP-1) released from distal intestinal endocrine L cells after food intake is a potent glucose-dependent stimulant of insulin secretion. Plasma levels of GLP-1 rise rapidly after nutrient ingestion through an indirect mechanism triggered from the proximal intestine and involving the vagus nerve. Our previous studies showed the involvement of M1 muscarinic receptors expressed by the L cells in the regulation of postprandial GLP-1 secretion in rats. The goal of this study was to explore the involvement of muscarinic receptors in the regulation of GLP-1 secretion by human L cells using a newly described human L cell line (NCI-H716). Phorbol 12-myristate 13-acetate (positive control) stimulated GLP-1 secretion to 252 ± 38% of the control (P < 0.001). Bethanechol, a nonselective muscarinic agonist, significantly stimulated GLP-1 secretion to 187 ± 20% of the control (P < 0.01, n = 8). Pirenzepine (M1 antagonist; 101000 µM) and gallamine (M2 antagonist; 101000 µM) completely inhibited bethanechol-induced GLP-1 secretion, whereas 4-diphenylacetoxy-N-methylpiperidine (M3 antagonist) had no effect on bethanechol-stimulated GLP-1 secretion. McN-A-343 (M1 muscarinic agonist) dose dependently stimulated GLP-1 secretion (to 252 ± 50% of control at 1000 µM; P < 0.01), whereas oxotremorine (M3 agonist) had no effect. M1, M2, and M3 muscarinic receptors were shown to be expressed in NCI-H716 cells by Western blot, immunohystochemistry, and RT-PCR. Expression of the M1, M2, and M3 muscarinic receptor subtypes was also confirmed in paraffin-embedded human small intestine sections by double immunofluorescent staining. These results demonstrate the role of M1 and M2 muscarinic receptors expressed by human L cells in the control of GLP-1 secretion.
This article has been cited by other articles:
![]() |
J.-i. Eiki, K. Saeki, N. Nagano, T. Iino, M. Yonemoto, Y. Takayenoki-Iino, S. Ito, T. Nishimura, Y. Sato, M. Bamba, et al. A selective small molecule glucagon-like peptide-1 secretagogue acting via depolarization-coupled Ca2+ influx J. Endocrinol., June 1, 2009; 201(3): 361 - 367. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. Lauffer, R. Iakoubov, and P. L. Brubaker GPR119 Is Essential for Oleoylethanolamide-Induced Glucagon-Like Peptide-1 Secretion From the Intestinal Enteroendocrine L-Cell Diabetes, May 1, 2009; 58(5): 1058 - 1066. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. E. Lim, G. J. Huang, N. Flora, D. LeRoith, C. J. Rhodes, and P. L. Brubaker Insulin Regulates Glucagon-Like Peptide-1 Secretion from the Enteroendocrine L Cell Endocrinology, February 1, 2009; 150(2): 580 - 591. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Shah, S. Khurana, K. Cheng, and J.-P. Raufman Muscarinic receptors and ligands in cancer Am J Physiol Cell Physiol, February 1, 2009; 296(2): C221 - C232. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Kim and J. M. Egan The Role of Incretins in Glucose Homeostasis and Diabetes Treatment Pharmacol. Rev., December 1, 2008; 60(4): 470 - 512. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Burcelin, P. D. Cani, and C. Knauf Glucagon-Like Peptide-1 and Energy Homeostasis J. Nutr., November 1, 2007; 137(11): 2534S - 2538S. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Holst The Physiology of Glucagon-like Peptide 1 Physiol Rev, October 1, 2007; 87(4): 1409 - 1439. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Chaikomin, K. L. Wu, S. Doran, K. L. Jones, A. J. P. M. Smout, W. Renooij, R. H. Holloway, J. H. Meyer, M. Horowitz, and C. K. Rayner Concurrent duodenal manometric and impedance recording to evaluate the effects of hyoscine on motility and flow events, glucose absorption, and incretin release Am J Physiol Gastrointest Liver Physiol, April 1, 2007; 292(4): G1099 - G1104. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Iakoubov, A. Izzo, A. Yeung, C. I. Whiteside, and P. L. Brubaker Protein Kinase C{zeta} Is Required for Oleic Acid-Induced Secretion of Glucagon-Like Peptide-1 by Intestinal Endocrine L Cells Endocrinology, March 1, 2007; 148(3): 1089 - 1098. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. E. Lim and P. L. Brubaker Glucagon-Like Peptide 1 Secretion by the L-Cell: The View From Within Diabetes, December 1, 2006; 55(Supplement_2): S70 - S77. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. W. Nelson, X. Liu, J. J. Holst, H. E. Raybould, and D. M. Ney Vagal afferents are essential for maximal resection-induced intestinal adaptive growth in orally fed rats. Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2006; 291(5): R1256 - R1264. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Rozengurt, S. V. Wu, M. C. Chen, C. Huang, C. Sternini, and E. Rozengurt Colocalization of the {alpha}-subunit of gustducin with PYY and GLP-1 in L cells of human colon Am J Physiol Gastrointest Liver Physiol, November 1, 2006; 291(5): G792 - G802. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A Reimer Meat hydrolysate and essential amino acid-induced glucagon-like peptide-1 secretion, in the human NCI-H716 enteroendocrine cell line, is regulated by extracellular signal-regulated kinase1/2 and p38 mitogen-activated protein kinases. J. Endocrinol., October 1, 2006; 191(1): 159 - 170. [Abstract] [Full Text] [PDF] |
||||
![]() |
F Reimann, M Maziarz, G Flock, A. M Habib, D. J Drucker, and F. M Gribble Characterization and functional role of voltage gated cation conductances in the glucagon-like peptide-1 secreting GLUTag cell line J. Physiol., February 15, 2005; 563(1): 161 - 175. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Hansen, S. Lampert, H. Mineo, and J. J. Holst Neural regulation of glucagon-like peptide-1 secretion in pigs Am J Physiol Endocrinol Metab, November 1, 2004; 287(5): E939 - E947. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |